CIM Brca1 2 AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A consortium of investigators of modifiers of BRCA1/2 study

Abstrakt

unknown clinical sitnificance, DNA sequence variants, aurora-A, susceptibility gnes, mouse